Xiaodan Yang Selected Research

proto-oncogene protein Pbx3

8/2020

MG132 inhibits the expression of PBX3 through miRNAs by targeting Argonaute2 in hepatoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaodan Yang Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 12/2013
4	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 11/2019
3	Tics (Tic) 11/2021 - 01/2019
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 01/2018
3	Adenocarcinoma of Lung 01/2021 - 05/2015
3	Carcinogenesis 01/2021 - 11/2018
3	Infections 10/2020 - 01/2018
3	Sarcoma (Soft Tissue Sarcoma) 04/2016 - 05/2015
2	Inflammation (Inflammations) 01/2022 - 01/2019
2	Stroke (Strokes) 01/2022 - 04/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 01/2018
2	Vesicular Stomatitis 02/2016 - 01/2016
1	Massive Hepatic Necrosis 04/2022
1	Endotoxemia 01/2022
1	Ischemic Stroke 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Insulin Resistance 01/2022
1	Dysbiosis 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Circulating Neoplastic Cells 10/2021
1	Thrombocytopenia (Thrombopenia) 10/2021
1	Lentivirus Infections 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Adenocarcinoma 11/2020
1	Liver Neoplasms (Liver Cancer) 08/2020
1	Coinfection 08/2020
1	Leukemia 08/2020
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 04/2020
1	Arteriosclerosis 04/2020
1	Neoplasm Metastasis (Metastasis) 11/2019
1	Bone Resorption 01/2019
1	Movement Disorders (Movement Disorder) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Embryonal Rhabdomyosarcoma 01/2018
1	Burns 10/2017
1	Corneal Opacity 10/2017
1	Edema (Dropsy) 10/2017
1	Liposarcoma 09/2017
1	Virus Diseases (Viral Diseases) 01/2017

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2016
3	Calcium Channels (Calcium Channel)IBA 11/2021 - 01/2019
3	MicroRNAs (MicroRNA)IBA 08/2020 - 11/2018
2	CytokinesIBA 04/2022 - 10/2020
2	Indicators and Reagents (Reagents)IBA 01/2022 - 11/2020
2	Peptides (Polypeptides)IBA 01/2022 - 01/2021
2	Gemcitabine FDA Link 10/2021 - 01/2018
2	VaccinesIBA 01/2021 - 10/2020
2	Messenger RNA (mRNA)IBA 01/2021 - 08/2020
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 10/2020
2	Phosphotransferases (Kinase)IBA 01/2018 - 01/2017
2	Tyrosine Kinase InhibitorsIBA 09/2017 - 01/2016
2	Antiviral Agents (Antivirals)IBA 02/2016 - 01/2016
1	Concanavalin AIBA 04/2022
1	Saline SolutionIBA 04/2022
1	Metformin (Glucophage)FDA LinkGeneric 04/2022
1	Cytidine Triphosphate (CTP)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	EndotoxinsIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Therapeutic UsesIBA 11/2021
1	CalcineurinIBA 11/2021
1	CalciumIBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	CrizotinibIBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 11/2020
1	Immune Checkpoint InhibitorsIBA 10/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2020
1	UbiquitinIBA 08/2020
1	Proteasome InhibitorsIBA 08/2020
1	proto-oncogene protein Pbx3IBA 08/2020
1	Transcription Factor 3IBA 08/2020
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 08/2020
1	Plasminogen Activator Inhibitor 1IBA 04/2020
1	AdipokinesIBA 04/2020
1	Interleukin-6 (Interleukin 6)IBA 04/2020
1	Sorafenib (BAY 43-9006)FDA Link 03/2020
1	Pharmaceutical PreparationsIBA 11/2019
1	CXCR3 ReceptorsIBA 01/2019
1	ChemokinesIBA 01/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2019
1	InterferonsIBA 01/2018
1	endostar proteinIBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	sodium arsenite (sodium metaarsenite)IBA 01/2018
1	AMP-Activated Protein KinasesIBA 01/2018
1	Histones (Histone)IBA 10/2017
1	ChromatinIBA 10/2017
1	apatinibIBA 09/2017
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2016
1	Bevacizumab (Avastin)FDA Link 04/2016

Therapy/Procedure

6	Therapeutics 11/2021 - 01/2016
4	Drug Therapy (Chemotherapy) 11/2021 - 09/2017
3	Immunotherapy 01/2022 - 10/2020
1	Transplantation 01/2021
1	Punctures 11/2019
1	Deep Brain Stimulation 01/2019
1	Ovariectomy (Oophorectomy) 01/2019
1	Lasers (Laser) 10/2017
1	Radiotherapy 09/2017